CASI Pharmaceuticals (CASIF) Cost of Revenue (2022 - 2025)
CASI Pharmaceuticals' Cost of Revenue was $3.53 million in Q4 2025, down 65.2% from $10.13 million a year earlier but up 49.0% from the prior quarter.
Powered by 
Analysis
CASI Pharmaceuticals (CASIF) Cost of Revenue (2022 - 2025) Analysis & Trends
For FY2025, Cost of Revenue at CASI Pharmaceuticals came in at $10.64 million, down 38.8% from FY2024.
- Cost of Revenue shows a five-year compound annual growth rate of 2.3% (FY2020 to FY2025).
- In earlier years, Cost of Revenue was $17.39 million in FY2024 (+25.8%), $13.83 million in FY2023 (-12.6%), $15.83 million in FY2022 (+26.0%) and $12.56 million in FY2021 (+32.1%).
- Quarterly Cost of Revenue has moved between $1.6 million (Q1 2024) and $10.13 million (Q4 2024) over five years.
- Compared with a year earlier, Cost of Revenue was higher in four of the last eight quarters, with growth averaging 16.3%.
- The best year-over-year quarter for Cost of Revenue over five years was Q4 2024 (growth of 259.8%); the worst was Q4 2025 (a decline of 65.2%).
- Per Business Quant data, CASIF's Cost of Revenue in the three quarters before Q4 2025 was $2.37 million (Q3 2025), $2.12 million (Q2 2025) and $2.62 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | CASI Pharmaceuticals | 2.47 Mn | -18.36 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 3.53 Mn |
| Sep 30, 2025 | 2.37 Mn |
| Jun 30, 2025 | 2.12 Mn |
| Mar 31, 2025 | 2.62 Mn |
| Dec 31, 2024 | 10.13 Mn |
| Sep 30, 2024 | 3.75 Mn |
| Jun 30, 2024 | 1.91 Mn |
| Mar 31, 2024 | 1.60 Mn |
| Dec 31, 2023 | 2.82 Mn |
| Sep 30, 2023 | 3.65 Mn |
| Jun 30, 2023 | 3.99 Mn |
| Mar 31, 2023 | 3.38 Mn |
| Dec 31, 2022 | 4.27 Mn |
| Sep 30, 2022 | 4.25 Mn |
| Jun 30, 2022 | 3.55 Mn |
| Mar 31, 2022 | 3.76 Mn |
API Access
CASI Pharmaceuticals Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=CASIF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "CASIF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=CASIF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();